미국 University of California, Irvine, Gavin Herbert Eye Institute 연수(2019.3~2020.3)
가톨릭대학교 서울성모병원 안과(전)
가톨릭대학교 대학원 의학과(박사)
가톨릭대학교 대학원 의학과(석사)
가톨릭대학교 의과대학 의학과 졸업
■ 관련경력
한국 백내장굴절수술학회 기획이사
국민연금공단 자문의사 (2017.12~2020.12)
의료사고감정단 자문위원 (2020.5~2023.5)
■ 주요논문
Shin J, Ra H, Rho CR. Herpes simplex virus linear endotheliitis in a post-keratoplasty patient: A case report. Medicine (Baltimore). 2019 Jan;98(3):e14191.
Rho CR, Kim H, Kim MS, Kim EC. Income and Education are Independently Associated with Visual Impairment: The Korean National Health and Nutrition Examination Survey 2010-2012. Semin Ophthalmol. 2019;34(3):131-136.
Kim JS, Ra H, Rho CR. Retrospective observational study of micro-monovision small incision lenticule extraction (SMILE) for the correction of presbyopia and myopia. Medicine (Baltimore). 2018 Dec;97(49):e13586.
Rho CR, Kim MJ, Joo CK. Influence of across-pupil sutures on the optical quality of intraocular lenses. Int Ophthalmol. Int Ophthalmol. 2018 Jun;38(3):909-915.
Kang S, Choi H, Rho CR. Differential Effects of Bevacizumab, Ranibizumab, and Aflibercept on the Viability and Wound Healing of Corneal Epithelial Cells. J Ocul Pharmacol Ther. 2016 Dec;32(10):671-676.
Rho CR, Kim MJ, Joo CK. Polar Value Analysis of Corneal Astigmatism in Intrastromal Corneal Ring Segment Implantation. J Ophthalmol. 2016;2016:7127534.
Rho CR, Park MY, Kang S. Effects of Granulocyte-Macrophage Colony-Stimulating (GM-CSF) Factor on Corneal Epithelial Cells in Corneal Wound Healing Model. PLoS One. 2015;10(9):e0138020.
Rho CR, Choi JS, Seo M, Lee SK, Joo CK. Inhibition of Lymphangiogenesis and Hemangiogenesis in Corneal Inflammation by Subconjunctival Prox1 siRNA Injection in Rats. Invest Ophthalmol Vis Sci. 2015;56(10):5871-9.
Cho WK, Kang S, Choi H, Rho CR. Topically administered gold nanoparticles inhibit experimental corneal neovascularization in mice. Cornea. 2015;34(4):456-9
Rho CR, Kang S, Park KC, Yang KJ, Choi H, Cho WK. Antiangiogenic Effects of Topically Administered Multiple Kinase Inhibitor, Motesanib (AMG 706), on Experimental Choroidal Neovascularization in Mice. J Ocul Pharmacol Ther. 2015;31(1):25-31.
Rho CR, Park JH, Jung YH, Kim MS. A case of concomitant keratoconus and granular corneal dystrophy type II. Cont Lens Anterior Eye. 2014;37(4):314-6.
Rho CR, Pandey C, Kim SY, Kim MS. Corneal swelling caused by conventional and new-design low-Dk soft contact lenses following a 10-day daily wear trial regime. Cont Lens Anterior Eye. 2014;37(1):38-43.
Rho CR, Na KS, Yoo YS, Pandey Chitra, Park CW, Joo CK. Changes in anterior and posterior corneal parameters in patients with keratoconus after intrastomal corneal-ring segment implantation. Curr Eye Res 2013;38(8):843-50.
Rho CR, Joo CK. Effects of steep meridian incision on corneal astigmatism in phacoemulsification cataract surgery. J Cataract Refract Surg 2012;38(4):666-71.
Rho CR, Park HY, Lee NY, Park CK. Clock-hour laminar displacement and age in primary open angle glaucoma and normal tension glaucoma. Clin Experiment Ophthalmol 2012;40(4):e183-9.
Kim SW, Rho CR, Kim J, Xie Y, Prince RC, Mustafa K, Potma EO, Brown DJ, Jester JV. Eicosapentaenoic acid (EPA) activates PPARγ signaling leading to cell cycle exit, lipid accumulation, and autophagy in human meibomian gland epithelial cells (hMGEC). Ocul Surf. 2020 Jul;18(3):427-437.
Byun YS, Rho CR, Cho K, Choi JA, Na KS, Joo CK. Cyclosporine 0.05% ophthalmic emulsion for dry eye in Korea: a prospective, multicenter, open-label, surveillance study. Korean J Ophthalmol. 2011 25(6):369-74.
Cho KJ, Mok JW, Na KS, Rho CR, Byun YS, Hwang HS, Hwang KY, Joo CK. TGFBI gene mutations in a Korean population with corneal dystrophy. Mol Vis. 2012;18:2012-21.
Na KS, Mok JW, Kim JY, Rho CR, Joo CK. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Invest Ophthalmol Vis Sci. 2012 13;53(9):5443-50.
Kang S, Roh CR, Cho WK, Park KC, Yang KJ, Choi HS, Kim SH, Roh YJ. Antiangiogenic effects of axitinib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on laser-induced choroidal neovascularization in mice. Curr Eye Res. 2013;38(1):119-27.
Seo M, Choi JS, Rho CR, Joo CK, Lee SK. MicroRNA miR-466 inhibits Lymphangiogenesis by targeting prospero-related homeobox 1 in the alkali burn corneal injury model. J Biomed Sci. 2015;22:3.
Roh YJ, Jee D, Rho CR, Cho WK, Kang S. Anti-angiogenic effect of ALS-L1023, an extract of Melissa officinalis L., on experimental choroidal neovascularization in mice. Clin Experiment Ophthalmol. 2015 Jul 29. doi: 10.1111/ceo.12583.
Jeung IC, Jee D, Rho CR, Kang S. Melissa Officinalis L. Extracts Protect Human Retinal Pigment Epithelial Cells against Oxidative Stress-Induced Apoptosis. Int J Med Sci. 2016 Feb 3;13(2):139-46.
Roh YJ, Rho CR, Cho WK, Kang S. The Antiangiogenic Effects of Gold Nanoparticles on Experimental Choroidal Neovascularization in Mice. Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6561-6567.
Kim HK, Choi JY, Park SM, Rho CR, Cho KJ, Jo SA. Tyrosine Kinase Inhibitor, Vatalanib, Inhibits Proliferation and Migration of Human Pterygial Fibroblasts. Cornea. 2017 Sep;36(9):1116-1123
■ 주요수상내역
ARVO Travel Grant Award. 2012.
JOS Travel Grant Award. 2012.
Asia-ARVO Travel Grant Award. 2015.
Santen Asia Education Grant. 2017.
■ 저 서
안과용어해설. 2011. 내외학술 (공저)
최신 백내장수술. 2013. 내외학술 (공저)
항상 궁금했던 각결막의 병태생리. 2014. 내외학술 (공저)
백내장. 제 3판. 2014. 일조각 (공저)
■ 임상연구
교정이 필요한 근시환자를 대상으로 눈물순환기능이 추가된 연성 콘택트렌즈가 기존 허가시판중인 연성콘택트렌즈와 비교하여 각막 부종 및 합병증을 감소시키는지에 대한 안전성과 유효성을 평가하기 위한 전향적, 다기관, 교차설계, 블록임의할당, 단일맹검 임상시험
안구건조증 피험자에서 CP-690,550 점안액의 제 II상 전향적, 무작위 배정, 이중 눈가림/시험자 눈가림, 위약 및 대조약 (히알우론산 나트륨 점안액) 대조, 용량범위결정 임상시험
중등도 이상의 안구건조증 환자에서 티스포린 점안액 0.05% 투여군과 레스타시스점안액 0.05% 투여군간 12주 치료후 유효성 및 안정성을 비교평가하기 위한 다기관 공동, 무작위배정, 이중눈가림, 활성군 대조, 병행 제3상 임상시험 (PI)
중등도 이상의 안구건조증으로 인해 눈물생성이 억제된 환자에서 TJCS 투여군과 레스타시스점안액 0.05% 투여군간 12주 치료 후 안전성 및 유효성을 비교평가하기 위한 다기관 공동, 무작위배정, 이중눈가림, 활성군 대조, 병행설계 제 3상 임상시험 (PI)
안구건조증 환자를 대상으로 HU00701/HU007 점안제의 유효성과 안전성을 평가하기 위한 다기관, 위약 대조, 참조군 병행, 무작위배정, 이중눈가림, 제2상 임상시험 (PI)
중등도 이상의 안구건조증으로 인해 눈물생성이 억제된 환자에서 KJCS-005 투여군과 레스타시스점안액 0.05% 투여군간 12주 치료 후 안전성 및 유효성을 비교평가하기 위한 다기관 공동, 무작위배정, 시험자 눈가림, 활성군 대조, 병행설계 제 3상 임상시험
오전 / 일정이 없습니다.(04/28~05/04)
오후 / 일정이 없습니다.(04/28~05/04)
약력
가톨릭대학교 대전성모병원 부교수
대한 안과학회 정회원
한국 외안부학회 정회원
한국 백내장굴절수술학회 정회원
미국 University of California, Irvine, Gavin Herbert Eye Institute 연수(2019.3~2020.3)
가톨릭대학교 서울성모병원 안과(전)
가톨릭대학교 대학원 의학과(박사)
가톨릭대학교 대학원 의학과(석사)
가톨릭대학교 의과대학 의학과 졸업
■ 관련경력
한국 백내장굴절수술학회 기획이사
국민연금공단 자문의사 (2017.12~2020.12)
의료사고감정단 자문위원 (2020.5~2023.5)
논문 & 주요활동
■ 주요논문
Shin J, Ra H, Rho CR. Herpes simplex virus linear endotheliitis in a post-keratoplasty patient: A case report. Medicine (Baltimore). 2019 Jan;98(3):e14191.
Rho CR, Kim H, Kim MS, Kim EC. Income and Education are Independently Associated with Visual Impairment: The Korean National Health and Nutrition Examination Survey 2010-2012. Semin Ophthalmol. 2019;34(3):131-136.
Kim JS, Ra H, Rho CR. Retrospective observational study of micro-monovision small incision lenticule extraction (SMILE) for the correction of presbyopia and myopia. Medicine (Baltimore). 2018 Dec;97(49):e13586.
Rho CR, Kim MJ, Joo CK. Influence of across-pupil sutures on the optical quality of intraocular lenses. Int Ophthalmol. Int Ophthalmol. 2018 Jun;38(3):909-915.
Kang S, Choi H, Rho CR. Differential Effects of Bevacizumab, Ranibizumab, and Aflibercept on the Viability and Wound Healing of Corneal Epithelial Cells. J Ocul Pharmacol Ther. 2016 Dec;32(10):671-676.
Rho CR, Kim MJ, Joo CK. Polar Value Analysis of Corneal Astigmatism in Intrastromal Corneal Ring Segment Implantation. J Ophthalmol. 2016;2016:7127534.
Rho CR, Park MY, Kang S. Effects of Granulocyte-Macrophage Colony-Stimulating (GM-CSF) Factor on Corneal Epithelial Cells in Corneal Wound Healing Model. PLoS One. 2015;10(9):e0138020.
Rho CR, Choi JS, Seo M, Lee SK, Joo CK. Inhibition of Lymphangiogenesis and Hemangiogenesis in Corneal Inflammation by Subconjunctival Prox1 siRNA Injection in Rats. Invest Ophthalmol Vis Sci. 2015;56(10):5871-9.
Cho WK, Kang S, Choi H, Rho CR. Topically administered gold nanoparticles inhibit experimental corneal neovascularization in mice. Cornea. 2015;34(4):456-9
Rho CR, Kang S, Park KC, Yang KJ, Choi H, Cho WK. Antiangiogenic Effects of Topically Administered Multiple Kinase Inhibitor, Motesanib (AMG 706), on Experimental Choroidal Neovascularization in Mice. J Ocul Pharmacol Ther. 2015;31(1):25-31.
Rho CR, Park JH, Jung YH, Kim MS. A case of concomitant keratoconus and granular corneal dystrophy type II. Cont Lens Anterior Eye. 2014;37(4):314-6.
Rho CR, Pandey C, Kim SY, Kim MS. Corneal swelling caused by conventional and new-design low-Dk soft contact lenses following a 10-day daily wear trial regime. Cont Lens Anterior Eye. 2014;37(1):38-43.
Rho CR, Na KS, Yoo YS, Pandey Chitra, Park CW, Joo CK. Changes in anterior and posterior corneal parameters in patients with keratoconus after intrastomal corneal-ring segment implantation. Curr Eye Res 2013;38(8):843-50.
Rho CR, Joo CK. Effects of steep meridian incision on corneal astigmatism in phacoemulsification cataract surgery. J Cataract Refract Surg 2012;38(4):666-71.
Rho CR, Park HY, Lee NY, Park CK. Clock-hour laminar displacement and age in primary open angle glaucoma and normal tension glaucoma. Clin Experiment Ophthalmol 2012;40(4):e183-9.
Kim SW, Rho CR, Kim J, Xie Y, Prince RC, Mustafa K, Potma EO, Brown DJ, Jester JV. Eicosapentaenoic acid (EPA) activates PPARγ signaling leading to cell cycle exit, lipid accumulation, and autophagy in human meibomian gland epithelial cells (hMGEC). Ocul Surf. 2020 Jul;18(3):427-437.
Byun YS, Rho CR, Cho K, Choi JA, Na KS, Joo CK. Cyclosporine 0.05% ophthalmic emulsion for dry eye in Korea: a prospective, multicenter, open-label, surveillance study. Korean J Ophthalmol. 2011 25(6):369-74.
Cho KJ, Mok JW, Na KS, Rho CR, Byun YS, Hwang HS, Hwang KY, Joo CK. TGFBI gene mutations in a Korean population with corneal dystrophy. Mol Vis. 2012;18:2012-21.
Na KS, Mok JW, Kim JY, Rho CR, Joo CK. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Invest Ophthalmol Vis Sci. 2012 13;53(9):5443-50.
Kang S, Roh CR, Cho WK, Park KC, Yang KJ, Choi HS, Kim SH, Roh YJ. Antiangiogenic effects of axitinib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on laser-induced choroidal neovascularization in mice. Curr Eye Res. 2013;38(1):119-27.
Seo M, Choi JS, Rho CR, Joo CK, Lee SK. MicroRNA miR-466 inhibits Lymphangiogenesis by targeting prospero-related homeobox 1 in the alkali burn corneal injury model. J Biomed Sci. 2015;22:3.
Roh YJ, Jee D, Rho CR, Cho WK, Kang S. Anti-angiogenic effect of ALS-L1023, an extract of Melissa officinalis L., on experimental choroidal neovascularization in mice. Clin Experiment Ophthalmol. 2015 Jul 29. doi: 10.1111/ceo.12583.
Jeung IC, Jee D, Rho CR, Kang S. Melissa Officinalis L. Extracts Protect Human Retinal Pigment Epithelial Cells against Oxidative Stress-Induced Apoptosis. Int J Med Sci. 2016 Feb 3;13(2):139-46.
Roh YJ, Rho CR, Cho WK, Kang S. The Antiangiogenic Effects of Gold Nanoparticles on Experimental Choroidal Neovascularization in Mice. Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6561-6567.
Kim HK, Choi JY, Park SM, Rho CR, Cho KJ, Jo SA. Tyrosine Kinase Inhibitor, Vatalanib, Inhibits Proliferation and Migration of Human Pterygial Fibroblasts. Cornea. 2017 Sep;36(9):1116-1123
■ 주요수상내역
ARVO Travel Grant Award. 2012.
JOS Travel Grant Award. 2012.
Asia-ARVO Travel Grant Award. 2015.
Santen Asia Education Grant. 2017.
■ 저 서
안과용어해설. 2011. 내외학술 (공저)
최신 백내장수술. 2013. 내외학술 (공저)
항상 궁금했던 각결막의 병태생리. 2014. 내외학술 (공저)
백내장. 제 3판. 2014. 일조각 (공저)
■ 임상연구
교정이 필요한 근시환자를 대상으로 눈물순환기능이 추가된 연성 콘택트렌즈가 기존 허가시판중인 연성콘택트렌즈와 비교하여 각막 부종 및 합병증을 감소시키는지에 대한 안전성과 유효성을 평가하기 위한 전향적, 다기관, 교차설계, 블록임의할당, 단일맹검 임상시험
안구건조증 피험자에서 CP-690,550 점안액의 제 II상 전향적, 무작위 배정, 이중 눈가림/시험자 눈가림, 위약 및 대조약 (히알우론산 나트륨 점안액) 대조, 용량범위결정 임상시험
중등도 이상의 안구건조증 환자에서 티스포린 점안액 0.05% 투여군과 레스타시스점안액 0.05% 투여군간 12주 치료후 유효성 및 안정성을 비교평가하기 위한 다기관 공동, 무작위배정, 이중눈가림, 활성군 대조, 병행 제3상 임상시험 (PI)
중등도 이상의 안구건조증으로 인해 눈물생성이 억제된 환자에서 TJCS 투여군과 레스타시스점안액 0.05% 투여군간 12주 치료 후 안전성 및 유효성을 비교평가하기 위한 다기관 공동, 무작위배정, 이중눈가림, 활성군 대조, 병행설계 제 3상 임상시험 (PI)
안구건조증 환자를 대상으로 HU00701/HU007 점안제의 유효성과 안전성을 평가하기 위한 다기관, 위약 대조, 참조군 병행, 무작위배정, 이중눈가림, 제2상 임상시험 (PI)
중등도 이상의 안구건조증으로 인해 눈물생성이 억제된 환자에서 KJCS-005 투여군과 레스타시스점안액 0.05% 투여군간 12주 치료 후 안전성 및 유효성을 비교평가하기 위한 다기관 공동, 무작위배정, 시험자 눈가림, 활성군 대조, 병행설계 제 3상 임상시험
